Testing Palbociclib (PD-0332991) as a Potential Targeted Treatment in Cancers With CCND1, 2, 3 Amplification (MATCH-Subprotocol Z1B)
Clinical trial NCT04439201 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04439201
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-31
- Primary completion
- 2021-03-09
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.